Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about MERCK & CO., INC.
09:01aMERCK : Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
AQ
07:33aMERCK : Gets FDA Approval for Verquvo
DJ
07:17aMERCK : Receives US FDA Approval of Heart Failure Treatment Verquvo
MT
06:46aMERCK : Announces U.S. FDA Approval of VERQUVO® (vericiguat)
BU
03:52aUPDATE : DeepMatter Jumps 18% on Multi-Year Data Licensing Contract with Merck's..
MT
03:09aDeepMatter Lands Multi-Year Data Licensing Contract With Merck's Life Science..
MT
01/14Philips Partners with Merck to Develop Digital Systems for Fertility Treatmen..
MT
01/13Ligand Pharmaceuticals to Receive $1.5 Million Milestone Payment From Merck
MT
01/13MERCK : Confirms Agreement with UNICEF to Establish the World's First Global Ebo..
PU
01/12EISAI : To present data on lenvima monotherapy and in combination with keytruda ..
AQ
01/12MERCK : Gets FDA Priority Review of V114 Vaccine for Adults
DJ
01/12MERCK : Says FDA Accepts for Priority Review the Biologics License Application f..
MT
01/12MERCK : U.S. FDA Accepts for Priority Review the Biologics License Application f..
BU
01/11MERCK : to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference ..
AQ
01/08Merck Create Advisory Panel to Address Company-Wide Digital Ethics
MT
01/08MERCK : to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference ..
BU
01/06CEOs Consider Ways to Smooth the Presidential Transition, Including Holding B..
DJ
01/05MERCK : Partners With Symvivo on BacTRL Platform Technology
MT
01/05Equities Climb in Early US Trading Led by Rise in Energy Sector as Oil Prices..
MT
01/04MERCK : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020MERCK : LYNPARZA Receives Three New Approvals in Japan
AQ
2020SECTOR UPDATE : Health Care Stocks Flat During Premarket Trading on Monday
MT
2020Japanese Regulator Approves AstraZeneca, Merck's Lynparza for Treatment of Ov..
MT
2020MERCK : LYNPARZA® (olaparib) Receives Three New Approvals in Japan
BU
2020GLOBAL MARKETS LIVE : Alibaba, Merck, Moderna…
2020MERCK : FDA's Oncologic Drugs Advisory Committee to Discuss Merck's Application ..
PU
2020MERCK : Working With A2 Biotherapeutics to Develop Investigational Cell Therapy ..
MT
2020MERCK : Lands $356 Million COVID-19 Treatment Supply Deal With US Government
MT
2020MERCK : Correction to Merck Article
DJ
2020MERCK : to Supply U.S. With Covid-19 Therapeutic
DJ
2020MERCK : Announces Supply Agreement with U.S. Government for Initial Doses of Inv..
BU
2020MERCK : FDA Grants Priority Review to Merck's Supplemental Biologics License App..
AQ
2020Arix Bioscience Closes $2.75 Billion Sale Of Portfolio Company VelosBio To Me..
MT
2020EISAI : LENVIMA plus KEYTRUDA Combination Demonstrated Statistically Significant..
AQ
2020MERCK : KEYTRUDA plus LENVIMA Combination Demonstrated Statistically Significant..
AQ
2020FDA Grants Priority Review for Merck's sBLA for Keytruda Plus Chemotherapy in..
MT
2020MERCK : FDA Grants Priority Review to Keytruda Plus Chemotherapy to Treat Types ..
DJ
2020MERCK : FDA Grants Priority Review to Merck's Supplemental Biologics License App..
BU
2020SECTOR UPDATE : Health Care Stocks Unable to Find Traction Wednesday
MT
2020SECTOR UPDATE : Health Care Stocks Still Looking for Direction
MT
2020MERCK : Eisai Say Keytruda Study Met Primary, Secondary Endpoints in Patients Wi..
MT
2020MERCK : KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combination Demonst..
BU
2020MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment i..
AQ
2020MERCK & CO., INC. : Ex-dividend day for
FA
2020ATTACKING DIVISIONAL PATENTS : Is A New Approach Emerging?
AQ
2020MERCK : Gets Positive Opinion From EU's CHMP on Keytruda for Types of Colorectal..
DJ
2020MERCK : Colon Cancer Treatment Candidate Gets Positive CHMP Opinion
MT
2020MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as First..
BU
2020Top CEOs Back Push to Create One Million Jobs for Black Americans
DJ
2020Aligos Therapeutics Climbs Amid Oligonucleotide Therapy Collaboration With Me..
MT
2020GLOBAL MARKETS LIVE: 3M, Amazon, Merck…
2020Merck, Artios Pharma Partner to Research, Develop Cancer Drugs
MT
2020Merck to Post Small Fourth-Quarter Gain After Divesting Stake in COVID-19 Vac..
MT
2020Equities Slide in Early US Trading as Salesforce Weighs on Dow, Private Payro..
MT
2020Merck Reports Selling Stake in Moderna After `Substantial Gain' Over Life of ..
MT
2020MERCK : Announces Sale of its Direct Equity Investment in Moderna
PU
2020MERCK : to Present at the 2020 Evercore ISI 3rd Annual HealthCONx Virtual Confer..
BU
2020OF MOLECULES & MEDICINE : Dr Maurice Hilleman ("The Father Of Modern Vaccines")
AQ
2020MERCK : Submits Applications for Licensure of V114, the Company's Investigationa..
AQ
2020CORCEPT THERAPEUTICS INCORPORATED : Appoints Gillian M. Cannon, PhD, to Board of..
AQ
2020MERCK : to Acquire OncoImmune
AQ
2020CLOSE UPDATE : Stocks End Higher as COVID-19 Vaccine Optimism Propels Energy, In..
MT
2020MIDDAY REPORT : US Stocks Edge Higher as Pandemic Worsens but More Vaccines Emer..
MT
2020Stocks Head Higher in Early US Trading as COVID-19 Vaccine, Treatments Start ..
MT
2020GLOBAL MARKETS LIVE: Boeing’s 737 Max to resume flights in Europe, Merck’s la..
2020SECTOR UPDATE : Health Care Stocks Rally Pre-Bell Monday
MT
2020MERCK : Correction to Merck to Buy OncoImmune Article
DJ
2020Merck Seeks to Boost COVID-19 Treatment Response in Deal to Acquire OncoImmun..
MT
2020Merck to Buy OncoImmune for $425 Million Amid Race for Covid-19 Treatments --..
DJ
2020Merck to Buy OncoImmune for $425 Million
MT
2020MERCK : Applies in U.S., Europe to License V114 Pneumococcal Conjugate Vaccine
DJ
2020Merck to Buy OncoImmune Amid Covid-19 Vaccine Development
DJ
2020MERCK : Submits Applications for Licensure of V114, the Company's Investigationa..
BU
2020MERCK : to Acquire OncoImmune
BU
2020EISAI : To present new investigational data on lenvima in thyroid cancer and ost..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MERCK & CO., INC.